We use analytics and advertising cookies, which you can accept or reject; see our privacy policy.

Current choice:

Wee1

Wee1 inhibitors act on a nuclear tyrosine kinase that delays entry into mitosis after DNA damage. Wee1 phosphorylates cyclin-dependent kinase 1 (CDK1) on tyrosine 15 and so keeps the CDK1-cyclin B complex inactive, as shown for the human enzyme in 1992. Protein kinase membrane-associated tyrosine/threonine 1 (PKMYT1) phosphorylates CDK1 on both threonine 14 and tyrosine 15. Blocking these kinases pushes cells with damaged DNA into premature mitosis. This effect is studied together with DNA-damaging agents, often in tumor cells that lack a functional G1 checkpoint. Adavosertib is a selective Wee1 inhibitor, whereas PD0166285 and PD 407824 also block checkpoint kinases listed under Chk. XH-30 inhibits PKMYT1, and HEMTAC WEE1 degrader-1 removes Wee1 by targeted degradation.

Items 26-47 of 47

  • Myt1-IN-3
    Cat. No.
    A57249
    CAS No.
    2719793-54-9

    Myt1-IN-3

    Myt1-IN-3 is a potent inhibitor of Myt1, a membrane-associated kinase that specifically targets tyrosine and threonine residues and inhibits cdc2 activity. With an IC50 of less than 10 nM, it effectively modulates Myt1 activity, making it a valuable tool for investigating cell cycle regulation. This compound is suitable for research applications focused on cancer biology, cell proliferation, and kinase signaling pathways.

    In stock View Details
    1 mg
    $160.00
    5 mg
    $385.00
    All 6 sizes
  • Myt1-IN-1
    Cat. No.
    A57250
    CAS No.
    2719749-02-5

    Myt1-IN-1

    Myt1-IN-1 is a potent inhibitor of Myt1 (PKMYT1), a membrane-associated kinase that specifically targets tyrosine and threonine residues with an IC50 of less than 10 nM. This compound exhibits significant anticancer activity, making it a valuable tool for research focused on cell cycle regulation and cancer therapeutics. Myt1-IN-1 is useful for studies investigating the role of Myt1 in tumor progression and offers insights into potential treatment strategies for various cancers.

    In stock View Details
    5 mg
    $260.00
    10 mg
    $430.00
    All 5 sizes
  • WEE1/PKMYT1-IN-1
    Cat. No.
    A57252
    CAS No.
    3047737-15-2

    WEE1/PKMYT1-IN-1

    WEE1/PKMYT1-IN-1 is a potent inhibitor targeting WEE1 and PKMYT1 kinases. This compound exhibits significant antiproliferative activity, making it suitable for research applications in cancer biology. It can be utilized to investigate cell cycle regulation and the mechanistic pathways involved in tumor cell proliferation.

    In stock View Details
    5 mg
    $535.00
    10 mg
    $880.00
    All 5 sizes
  • PKMYT1-IN-1
    Cat. No.
    A57253
    CAS No.
    3033609-83-2

    PKMYT1-IN-1

    PKMYT1-IN-1 is a selective inhibitor of the membrane-associated tyrosine and threonine kinase, PKMYT1, demonstrating an IC50 of 8.8 nM. This reagent effectively inhibits the proliferation of HCC1569 tumor cells with an IC50 of 42 nM, making it a valuable tool for research into cancer biology and therapeutic interventions targeting PKMYT1 pathways. Its specificity and potency offer significant potential for studying the role of PKMYT1 in oncogenic processes.

    In stock View Details
    5 mg
    $370.00
    10 mg
    $605.00
    All 5 sizes
  • Myt1-IN-2
    Cat. No.
    A57254
    CAS No.
    2719748-43-1

    Myt1-IN-2

    Myt1-IN-2 is a potent inhibitor of the membrane-associated cdc2-inhibitory kinase, Myt1 (Gene name: PKMYT1), demonstrating an IC50 of less than 10 nM. This compound exhibits significant antitumor activity, making it a valuable tool for cancer research. Myt1-IN-2 can be utilized in studies aimed at elucidating the role of Myt1 in cell cycle regulation and its implications in oncogenesis.

    In stock View Details
    25 mg
    $1,800.00
    50 mg
    $2,285.00
    All 3 sizes
  • LEB-03-144
    Cat. No.
    A57255
    CAS No.
    2858812-89-0

    LEB-03-144

    LEB-03-144 is a WEE1 DUBTAC (deubiquitinase-targeting chimera) designed to link AZD1775 (Adavosertib) with the OTUB1 recruiter EN523 via a C3 alkyl linker. This compound demonstrates notable stabilization of WEE1 in HEP3B hepatoma cancer cells, indicating its potential role in enhancing the therapeutic efficacy of WEE1 inhibition. LEB-03-144 is suitable for studies focused on cancer biology and drug discovery applications targeting WEE1-mediated signaling pathways.

    View Details

    Out of stock

    All 3 sizes
  • PKMYT1-IN-9
    Cat. No.
    A57256
    CAS No.
    3055031-36-9

    PKMYT1-IN-9

    PKMYT1-IN-9 is a selective inhibitor of PKMYT1, demonstrating an IC50 of 4.4 nM. This compound shows significantly higher selectivity for PKMYT1 compared to WEE1, which has an IC50 of 32.4 μM. PKMYT1-IN-9 has been characterized by its antitumor activity, making it a valuable tool in cancer research and therapeutic studies targeting checkpoint pathways.

    View Details

    Out of stock

    All 3 sizes
  • WEE1-IN-12
    Cat. No.
    A57257
    CAS No.
    3069940-37-7

    WEE1-IN-12

    WEE1-IN-12 is a potent Wee1 kinase inhibitor with an IC50 of 2.0 nM. It demonstrates significant antiproliferative effects in HT29 colorectal cancer cells, exhibiting an IC50 of 1.07 μM. The compound enhances the efficacy of Gemcitabine, showing improved activity with an IC50 of 0.34 μM in combination studies. WEE1-IN-12 is valuable for research into targeted therapies for tumors, particularly colon cancer.

    View Details

    Out of stock

    All 3 sizes
  • PKMYT1-IN-2
    Cat. No.
    A57258
    CAS No.
    3033609-84-3

    PKMYT1-IN-2

    PKMYT1-IN-2 is a potent inhibitor of PKMYT1, exhibiting an IC50 value of 5.7 nM. This compound effectively suppresses the growth of HCC1569 cancer cells with an IC50 of 22 nM. PKMYT1-IN-2 serves as a valuable tool for research in cancer biology, particularly in studies focused on targeting the PKMYT1 pathway for therapeutic interventions.

    View Details

    Out of stock

    All 3 sizes
  • WEE1/PKMYT1-IN-2
    Cat. No.
    A57259
    CAS No.
    3047759-59-8

    WEE1/PKMYT1-IN-2

    WEE1/PKMYT1-IN-2 is a potent inhibitor of WEE1 and PKMYT1 kinases, exhibiting an axial chiral P configuration. This compound demonstrates significant antiproliferative activity, making it a valuable tool for cancer research. It is particularly relevant for studies investigating cell cycle regulation and the therapeutic potential of targeting WEE1 and PKMYT1 in various malignancies.

    View Details

    Out of stock

    All 3 sizes
  • i-AZD1775 TFA
    Cat. No.
    A57260
    CAS No.
    2858813-30-4

    i-AZD1775 TFA

    i-AZD1775 TFA is an immobilizable analogue of AZD1775, functioning as a selective inhibitor of the WEE1 kinase. This compound exhibits significant potential in inhibiting cell cycle regulation, enabling the investigation of its efficacy in cancer cell lines. i-AZD1775 TFA is valuable for studies focused on anticancer therapies, particularly in exploring combination treatments and resistance mechanisms in various tumor types.

    View Details

    Out of stock

    All 3 sizes
  • WEE1-IN-9
    Cat. No.
    A57261
    CAS No.
    2510782-14-4

    WEE1-IN-9

    WEE1-IN-9 is a selective inhibitor of the Wee1 kinase, which plays a critical role in regulating the cell cycle by inhibiting the progression from G2 to mitosis. This compound exhibits potent anti-tumor activity and is valuable for studying the effects of Wee1 inhibition in cancer research. WEE1-IN-9 can be utilized in investigations of cancer cell proliferation and therapy resistance mechanisms, contributing to the development of novel cancer treatments.

    View Details

    Out of stock

    All 3 sizes
  • WEE1-IN-6
    Cat. No.
    A57262
    CAS No.
    2928524-08-5

    WEE1-IN-6

    WEE1-IN-6 is a potent WEE1 inhibitor with a DC50 value of ≤ 100 nM. This compound effectively inhibits cell proliferation, making it a valuable tool for studies related to cell cycle regulation and cancer research. Its oral bioactivity enables convenient administration in various in vivo studies targeting WEE1 pathways.

    View Details

    Out of stock

    All 3 sizes
  • WEE1/PKMYT1-IN-3
    Cat. No.
    A57263
    CAS No.
    3047759-60-1

    WEE1/PKMYT1-IN-3

    WEE1/PKMYT1-IN-3 is a potent inhibitor of WEE1 and PKMYT1, specifically designed with an axial chiral M configuration. This compound exhibits significant antiproliferative activity, making it a valuable tool for cancer research. It can be utilized to explore the mechanisms of cell cycle regulation and to investigate therapeutic strategies targeting these critical kinases in various malignancies.

    View Details

    Out of stock

    All 3 sizes
  • LEB-03-145
    Cat. No.
    A57264
    CAS No.
    2858812-90-3

    LEB-03-145

    LEB-03-145 is a WEE1 deubiquitinase-targeting chimera (DUBTAC) that effectively links AZD1775 (Adavosertib) to the OTUB1 recruiter EN523 via a C5 alkyl linker. This compound enhances the stability and activity of AZD1775 by modulating ubiquitination processes. LEB-03-145 is valuable for studying WEE1 regulation and offers potential in cancer research, particularly in the context of targeting tumor cell proliferation and survival pathways.

    View Details

    Out of stock

    All 3 sizes
  • WEE1-IN-8
    Cat. No.
    A57265
    CAS No.
    2493422-74-3

    WEE1-IN-8

    WEE1-IN-8 is a highly selective WEE1 inhibitor, exhibiting an IC50 of 0.98 nM. This compound is effective in research applications targeting various malignancies, including pancreatic cancer, ovarian cancer, colorectal cancer, and uterine serous carcinoma. By facilitating the abrogation of G2/M checkpoint control, WEE1-IN-8 demonstrates potential as a therapeutic agent in cancer treatment strategies.

    View Details

    Out of stock

    All 3 sizes
  • Adavosertib-C3-NH-Boc
    Cat. No.
    A57266
    CAS No.
    2113725-19-0

    Adavosertib-C3-NH-Boc

    Adavosertib-C3-NH-Boc is a target protein ligand-linker conjugate designed to incorporate a Wee1 ligand and a PROTAC linker, facilitating the recruitment of E3 ligases. This compound enables the synthesis of PROTAC Pomalidomide-C3-adavosertib, allowing for targeted protein degradation studies. It serves as a useful tool in the exploration of therapeutic mechanisms involving protein regulation and degradation in cancer research and other biological applications.

    View Details

    Out of stock

    All 3 sizes
  • PKMYT1-IN-11
    Cat. No.
    A57267
    CAS No.
    3097325-25-9

    PKMYT1-IN-11

    PKMYT1-IN-11 is a potent inhibitor of PKMYT1, exhibiting an IC50 of 4.49 nM. This compound effectively suppresses the proliferation of HCC1569 cancer cells and demonstrates a significant anti-tumor effect in combination with Gemcitabine in the OVCAR3 xenograft mouse model. PKMYT1-IN-11 is valuable for researching various cancers, including breast and ovarian cancer, providing insights into therapeutic strategies targeting PKMYT1.

    View Details

    Out of stock

    All 3 sizes
  • WEE1-IN-11
    Cat. No.
    A57268
    CAS No.
    2975172-98-4

    WEE1-IN-11

    WEE1-IN-11 is a potent inhibitor of the Wee1 kinase, demonstrating an impressive IC50 of 2.0 nM against CDK2. This compound effectively inhibits various cancer cell lines, including NCI-H446, A427, OVCAR3, C33A, and WiDr, with IC50 values of 93.9 nM, 34.5 nM, 86.7 nM, 23.1 nM, and 85 nM, respectively. It serves as a valuable tool for investigating cell cycle regulation and the therapeutic potential of targeting Wee1 in cancer research.

    View Details

    Out of stock

    All 3 sizes
  • LEB-03-153
    Cat. No.
    A57269
    CAS No.
    2858812-88-9

    LEB-03-153

    LEB-03-153 is a WEE1 deubiquitinase-targeting chimera (DUBTAC) designed to effectively recruit OTUB1 to the WEE1 protein via a novel mechanism. This compound facilitates the modulation of WEE1 activity, potentially influencing cell cycle progression and enhancing the therapeutic effects of AZD1775 (Adavosertib). LEB-03-153 is ideal for research applications involving cancer biology, particularly in studies focused on checkpoint regulation and therapeutic resistance.

    View Details

    Out of stock

    All 3 sizes
  • PKMYT1-IN-4
    Cat. No.
    A57270
    CAS No.
    3047617-07-9

    PKMYT1-IN-4

    PKMYT1-IN-4 is a potent PKMYT1 inhibitor with an IC50 of less than 50 nM. This compound selectively targets the Wee1 kinase, a critical regulator of the cell cycle. PKMYT1-IN-4 is utilized in research applications focused on cell cycle regulation and cancer biology, making it suitable for studies exploring therapeutic strategies against proliferative diseases.

    View Details

    Out of stock

    All 3 sizes
  • Myt1-IN-6
    Cat. No.
    A57271
    CAS No.
    3056083-14-5

    Myt1-IN-6

    Myt1-IN-6 is a selective inhibitor of MYT1 kinase, which plays a crucial role in the regulation of cell cycle progression and neuronal differentiation. This compound is particularly relevant for studies involving RB1-deficient cancers, such as triple-negative breast cancer, where MYT1 activity may contribute to oncogenesis and tumor progression. Myt1-IN-6 serves as a valuable tool for exploring therapeutic strategies targeting MYT1 in various malignancies.

    View Details

    Out of stock

    All 3 sizes

Items 26-47 of 47

Added to your cart

View Cart Checkout

    Loading...